NEU neuren pharmaceuticals limited

Ann: 2024 Full Year Results webinar, page-24

  1. 1,476 Posts.
    lightbulb Created with Sketch. 373
    autism, alzheimers, etc according to Jon have all been put into the "too hard" basket (which I applaud and agree) - due to lack of orphan designation, endpoint work and agreement, these diseases have misdiagnosis involved, etc.

    If post takeover or partner someone else wants to do it using NNZ, then it could happen - but not on Jon's watch.

    He was VERY clear about this.

    Really hoping shareholders understand this and put the issue to bed - but im sure im grasping at straws, here....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.83
Change
-0.130(1.00%)
Mkt cap ! $1.574B
Open High Low Value Volume
$12.82 $13.05 $12.53 $5.607M 437.7K

Buyers (Bids)

No. Vol. Price($)
11 238 $12.81
 

Sellers (Offers)

Price($) Vol. No.
$12.82 22 2
View Market Depth
Last trade - 15.45pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.